<code id='3520B6B3A4'></code><style id='3520B6B3A4'></style>
    • <acronym id='3520B6B3A4'></acronym>
      <center id='3520B6B3A4'><center id='3520B6B3A4'><tfoot id='3520B6B3A4'></tfoot></center><abbr id='3520B6B3A4'><dir id='3520B6B3A4'><tfoot id='3520B6B3A4'></tfoot><noframes id='3520B6B3A4'>

    • <optgroup id='3520B6B3A4'><strike id='3520B6B3A4'><sup id='3520B6B3A4'></sup></strike><code id='3520B6B3A4'></code></optgroup>
        1. <b id='3520B6B3A4'><label id='3520B6B3A4'><select id='3520B6B3A4'><dt id='3520B6B3A4'><span id='3520B6B3A4'></span></dt></select></label></b><u id='3520B6B3A4'></u>
          <i id='3520B6B3A4'><strike id='3520B6B3A4'><tt id='3520B6B3A4'><pre id='3520B6B3A4'></pre></tt></strike></i>

          knowledge

          knowledge

          author:explore    Page View:72659
          Rep. Larry Bucshon (R-Ind.) received a significant amount of campaign donations from the pharmaceutical industry in the second quarter of 2023. House Television via AP

          WASHINGTON — The pharmaceutical industry has been flooding the campaign coffers of Rep. Larry Bucshon, a cardiothoracic surgeon and Republican from Indiana, according to a STAT analysis of this quarter’s filings.

          CEOs of pharmaceutical giants, executives of the brand-drug lobby PhRMA, and companies’ political action committees all gave in higher-than-usual numbers to the rank-and-file House member last quarter. The total was nearly $56,000 between April 14 and June 30.

          advertisement

          Bucshon is a member of the House Energy & Commerce Committee, which works on drug pricing issues, and the GOP Doctors Caucus, but he doesn’t hold leadership positions in either.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          focus

          Cancer drug shortages should be causing more outrage
          Cancer drug shortages should be causing more outrage

          DrugshortagesareagrowingproblemintheU.S.,andashortageoflivesavingcancerdrugsinparticularhasreachedcr

          read more
          The Karikó problem: Lessons for funding basic research
          The Karikó problem: Lessons for funding basic research

          AdobeNewscientificinstitutesarespringingupallovertheplacethesedays:ArcadiaScience,NewScience,ArcInst

          read more
          In age of alternative facts, a scholarly course on calling out crap
          In age of alternative facts, a scholarly course on calling out crap

          Screenshotviacallingbullshit.orgTiredofalternativefacts,fakenews,andbreathlesshyperbole,twoprofessor

          read more

          Study points to new risk in gene therapy death of Terry Horgan

          TerryHorganinhisfamily'sMontourFalls,N.Y.,home,inanundatedphoto.KateCollins/TheJournalviaAPLastOctob